MedTrace Logo

A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease

NCT00870077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2012-02-24

No results posted yet for this study

Summary

An increase in dietary protein intake has been shown to blunt the increase in intrahepatic fat induced by high fat feeding in healthy individuals. The purpose of this study is to determine if a protein supplementation decreases intrahepatic fat in obese patients with non-alcoholic fatty liver disease.

Conditions

  • Non-alcoholic Fatty Liver Disease
  • Obesity

Interventions

DIETARY_SUPPLEMENT

ProWHEY 94 CFM, SponserR

3 times 20g per day

Sponsors & Collaborators

  • University of Lausanne

    lead OTHER

Principal Investigators

  • Luc Tappy, MD · Centre Hospitalier Universitaire Vaudois

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-12-31
Completion
2010-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00870077 on ClinicalTrials.gov